|
Glaukos Corporation (GKOS) DCF Valuation
US | Healthcare | Medical - Devices | NYSE
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Glaukos Corporation (GKOS) Bundle
Simplify Glaukos Corporation (GKOS) valuation with this customizable DCF Calculator! Featuring real Glaukos Corporation (GKOS) financials and adjustable forecast inputs, you can test scenarios and uncover Glaukos Corporation (GKOS) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 237.0 | 225.0 | 294.0 | 282.9 | 314.7 | 340.7 | 368.9 | 399.5 | 432.5 | 468.3 |
| Revenue Growth, % | 0 | -5.07 | 30.7 | -3.79 | 11.26 | 8.27 | 8.27 | 8.27 | 8.27 | 8.27 |
| EBITDA | -37.6 | -83.6 | -1.5 | -48.8 | -82.1 | -66.0 | -71.5 | -77.4 | -83.8 | -90.7 |
| EBITDA, % | -15.87 | -37.16 | -0.50134 | -17.24 | -26.09 | -19.37 | -19.37 | -19.37 | -19.37 | -19.37 |
| Depreciation | 9.9 | 34.6 | 34.4 | 35.9 | 38.0 | 38.2 | 41.3 | 44.8 | 48.5 | 52.5 |
| Depreciation, % | 4.16 | 15.39 | 11.71 | 12.71 | 12.07 | 11.21 | 11.21 | 11.21 | 11.21 | 11.21 |
| EBIT | -47.5 | -118.2 | -35.9 | -84.7 | -120.1 | -104.2 | -112.8 | -122.1 | -132.2 | -143.2 |
| EBIT, % | -20.03 | -52.54 | -12.21 | -29.95 | -38.16 | -30.58 | -30.58 | -30.58 | -30.58 | -30.58 |
| Total Cash | 174.0 | 404.4 | 414.1 | 352.7 | 295.4 | 318.5 | 344.8 | 373.3 | 404.2 | 437.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 38.4 | 36.1 | 33.4 | 36.1 | 39.9 | 47.0 | 50.9 | 55.1 | 59.7 | 64.6 |
| Account Receivables, % | 16.21 | 16.03 | 11.37 | 12.75 | 12.66 | 13.81 | 13.81 | 13.81 | 13.81 | 13.81 |
| Inventories | 42.6 | 15.8 | 23.0 | 37.8 | 42.0 | 40.6 | 43.9 | 47.6 | 51.5 | 55.8 |
| Inventories, % | 17.97 | 7.03 | 7.83 | 13.38 | 13.34 | 11.91 | 11.91 | 11.91 | 11.91 | 11.91 |
| Accounts Payable | 5.8 | 4.4 | 7.3 | 14.4 | 13.4 | 11.1 | 12.0 | 13.0 | 14.0 | 15.2 |
| Accounts Payable, % | 2.44 | 1.94 | 2.49 | 5.09 | 4.27 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 |
| Capital Expenditure | -4.7 | -6.9 | -47.8 | -30.3 | -20.2 | -26.2 | -28.4 | -30.7 | -33.3 | -36.0 |
| Capital Expenditure, % | -1.99 | -3.08 | -16.25 | -10.7 | -6.43 | -7.69 | -7.69 | -7.69 | -7.69 | -7.69 |
| Tax Rate, % | -0.69844 | -0.69844 | -0.69844 | -0.69844 | -0.69844 | -0.69844 | -0.69844 | -0.69844 | -0.69844 | -0.69844 |
| EBITAT | 14.6 | -107.5 | -36.1 | -85.4 | -120.9 | -81.5 | -88.2 | -95.5 | -103.4 | -112.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -55.4 | -52.1 | -51.1 | -90.1 | -112.1 | -77.7 | -81.6 | -88.3 | -95.6 | -103.5 |
| WACC, % | 8.84 | 9.04 | 9.06 | 9.06 | 9.06 | 9.01 | 9.01 | 9.01 | 9.01 | 9.01 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -343.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -106 | |||||||||
| Terminal Value | -1,506 | |||||||||
| Present Terminal Value | -978 | |||||||||
| Enterprise Value | -1,321 | |||||||||
| Net Debt | 290 | |||||||||
| Equity Value | -1,612 | |||||||||
| Diluted Shares Outstanding, MM | 48 | |||||||||
| Equity Value Per Share | -33.28 |
What You Will Get
- Real GKOS Financial Data: Pre-filled with Glaukos Corporation’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Glaukos Corporation’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Financial Inputs: Adjust essential parameters such as revenue projections, EBITDA margins, and capital investments.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and other financial metrics in real-time.
- High-Precision Results: Leverages Glaukos Corporation's (GKOS) real financial data for accurate valuation insights.
- Effortless Scenario Testing: Easily explore various assumptions and analyze the resulting impacts.
- Efficiency Booster: Streamline the valuation process by avoiding the complexities of building models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review Glaukos Corporation’s pre-filled financial data and forecasts.
- Step 3: Modify critical inputs like revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Watch the DCF model update instantly as you tweak assumptions.
- Step 5: Analyze the outputs and use the results for investment decisions regarding Glaukos Corporation (GKOS).
Why Choose This Calculator for Glaukos Corporation (GKOS)?
- Designed for Experts: A sophisticated tool utilized by financial analysts, CFOs, and healthcare consultants.
- Accurate Data: Glaukos Corporation's historical and projected financials are preloaded for precision.
- Forecast Scenarios: Easily simulate various projections and assumptions for informed decision-making.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance ensures a seamless experience throughout the process.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for Glaukos Corporation (GKOS) analysis.
- Corporate Finance Departments: Evaluate valuation scenarios to inform strategic decisions within the company.
- Consultants and Financial Advisors: Deliver precise valuation insights to clients interested in Glaukos Corporation (GKOS) stock.
- Students and Instructors: Utilize real-time data to enhance learning and practice in financial modeling.
- Medical Technology Enthusiasts: Gain insights into how companies like Glaukos Corporation (GKOS) are valued in the healthcare market.
What the Glaukos Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for Glaukos Corporation (GKOS).
- Real-World Data: Glaukos’ historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Integrated analysis covering profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Interactive charts and tables providing clear, actionable results.